Clinical Trial Update: PCSK9 Inhibitors in Acute Ischemic Stroke Patients Undergoing Endovascular Therapy [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update on PCSK9 inhibitors for acute ischemic stroke patients undergoing endovascular therapy; Phase 2 and Phase 3 studies are not yet recruiting…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• Evolocumab (evolocumab)
• alirocumab (alirocumab)

Snippet

Sponsor: Nanfang Hospital, Southern Medical University | Conditions: Acute Ischemic Stroke | Phase 2, Phase 3 | Status: NOT_YET_RECRUITING